Related Experiment Video
Updated: Feb 26, 2026

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
The analytical process to search for metabolomics biomarkers
M D Luque de Castro1, F Priego-Capote1
1Department of Analytical Chemistry, Annex Marie Curie Building, Campus of Rabanales, University of Córdoba, E-14071, Córdoba, Spain; Institute of Biomedical Research Maimónides (IMIBIC), Reina Sofía University Hospital, University of Córdoba, E-14004, Córdoba, Spain; CIBER Fragilidad y Envejecimiento Saludable (CIBERfes), Instituto de Salud Carlos III, Spain.
Limited metabolomics biomarkers hinder clinical use. Analytical chemists identify critical improvements needed in experimental design, data, and metadata for reliable biomarker discovery and clinical adoption.
Area of Science:
- Analytical Chemistry
- Metabolomics
- Biomarker Discovery
Background:
- The field of metabolomics has seen extensive research, yet the number of validated biomarkers for clinical use remains limited.
- This discrepancy suggests potential issues within the analytical pipeline, hindering the translation of research findings into practical applications.
Purpose of the Study:
- To critically evaluate the analytical process in metabolomics research.
- To identify key areas requiring improvement to enhance biomarker discovery and facilitate clinical adoption.
Main Methods:
- Review of the entire analytical workflow, from biological sample collection and preparation to data acquisition and analysis.
- Critical assessment of experimental design, data integrity, and metadata standards.
Main Results:
- Significant gaps exist in the reporting of experimental details, compromising study reproducibility.
- Insufficient data and metadata are provided, hindering the validation and application of discovered biomarkers.
- Potential sources of error identified across sampling, separation, analysis, and data treatment stages.
Conclusions:
- Improvements in experimental transparency, data quality, and metadata standards are crucial for advancing metabolomics biomarker research.
- Addressing analytical process deficiencies is essential for successful biomarker implementation and clinical utility.

